Direct answer:The DMF holder issues LOAs, forwards them to the corresponding DMF and delivers a copy of the same authorization letter to the client. The applicant checks the authorized audience, materials and references and includes the copy in the relevant declaration.
LOA empowers who to quote what?
LOA (Letter of Authorization, power of reference) is issued by the DMF holder and allows the designated applicant to refer to information specified in the DMF for reference by FDA in the review of the relevant application. API, pharmacitical packageing or feeder suppliers may first confirm the legal entity with which the customer actually declared, which material was cited and the time of delivery planned when they received a request from the customer for LOA.
The confidential information in the complete DMF is transmitted by the holder to the FDA in accordance with the applicable procedures. The parties identify separately the quality of information required of the client and what is available for delivery.
What is the holder's and the applicant's submission separately?
| Role | Main Actions | Hand-over records |
|---|---|---|
| DMF holder or its authorized author | Check the range of existing documents, issue LOAs, transmit them to the corresponding DMF to the FDA and deliver the same copy to the authorized party. | Signing version, transmission sequence and reply, client acceptance confirmation. |
| Applicants for medicines or their declaration teams | Check if LOA is consistent with the application, actual materials and sources of manufacture and include a copy of LOA and the required reference information in the relevant declaration. | Declarations and references, copies of signatures received, internal review records. |
The parties may agree to exchange the results prior to submission. Sending a copy to the client only leaves the holder to hand over to the to-do; The submission to the FDA alone also leaves a client to-do.
What information needs to be checked before signing?
- Document identity:The legal name of the holder, the DMF number and the subject matter of the document should match the existing records.
- Authorized parties:The name of the legal person that actually relies on this document is used to check whether the procuring party, the agent and the applicant are the same subjects.
- Materials and references:Check the name of the material, the applicable specifications or models, the date of submission cited and the relevant sections. Where multiple sites or versions are involved, it should be confirmed that the material to be supplied has been covered by the relevant information.
- Issuance and transmission:Check the date, signatory identity and function to maintain the final version presented by both parties in conjunction with the FDA template to confirm the required field.
What if the client name, model or place of production is inconsistent?
For example, the purchase mail came from a corporate group and the application was submitted by its subsidiary. The holder should first ask the customer to confirm the actual declaration of the legal person. If LOA uses the name of the subject of the procurement, the application team should check whether corrections are required from the holder and then adopt the confirmed version.
If the customer’s proposed specifications or production sites are not covered by the existing DMF information, a check should be made of the need to supplement or revise the technical information before determining the reference scope of LOA and the order of submission of the application. The extension of the mandate in the delegation of authority could not by itself fill the missing technical information.
How do you make sure both parties are done after the launch of the LOA?
The holder checks the submission records of the DMF end and keeps a reply, and the applicant confirms that a copy of the LOA has been incorporated into the application. The DMF number, authorized object, material and reference range, date of issuance, serial delivery by the holder and the applicant’s confirmation date can be recorded in the handover form.
The electronic transmission of FDA is sent back to confirm the corresponding reception or processing status. The evaluation of relevant technical information by the FDA remains dependent on the application being cited and applied for the review. The project schedule shall record the status of receipt, completion of references and follow-up reviews, respectively.
How can new customers or materials be maintained after change?
When a new client is added, the new object is checked and the corresponding LOA is arranged. In the event of a change in the name, reference or supply specification of the original customer, check the existing authorization and technical records before confirming the need to submit an update. If you need to withdraw your authorization, you can check the FDA's Withdrawal of LOA template and coordinate the affected clients.
The list of authorizations can be maintained on a daily basis with the DMF version records. Technical changes affecting quoted information should be assessed separately for revision and communication, and the list of authorizations and documentation should be checked for annual maintenance.
FDA Original Text and Templates
- FDA《Drug Master Files: Guidelines》Section V describes the power of attorney and a copy of the applicant and section VII describes the holder’s maintenance. The electronic submission shall be made in conjunction with the existing electronic submission requirements.
- FDA DMF templateProvide LOA, withdraw LOA and annual report references.
- 21 CFR 314.420Description of the contents of the DMF, references to the authority and subsequent changes.
Let's get these four messages together before consulting.
The type and number of DDFs, materials and specifications, the customer’s reference requirements, and the time of submission are available first. Where there is a historical authorization or a document change, a list of documents may be provided first, and the mode of transfer of sensitive technical information is agreed upon separately.
Submit project status, check LOA authorization and submission。 If you have to prepare a first submission, technical revision or annual maintenance, you can check it. Drug Master File (DMF) Servicesand DMF and eCTD Basic Guide。